Compare MDLZ & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLZ | ELV |
|---|---|---|
| Founded | 2000 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.5B | 81.4B |
| IPO Year | 2001 | 2001 |
| Metric | MDLZ | ELV |
|---|---|---|
| Price | $61.28 | $379.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 19 |
| Target Price | $66.95 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 6.9M | 1.6M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.28% | 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.44 | ★ 8.00 |
| Revenue | $38,537,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $4.83 | N/A |
| Revenue Next Year | $3.10 | $3.07 |
| P/E Ratio | $139.74 | ★ $47.74 |
| Revenue Growth | 5.75 | ★ 12.49 |
| 52 Week Low | $51.20 | $273.71 |
| 52 Week High | $71.15 | $412.96 |
| Indicator | MDLZ | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 75.04 |
| Support Level | $60.32 | $305.50 |
| Resistance Level | $62.60 | $383.00 |
| Average True Range (ATR) | 1.17 | 9.16 |
| MACD | 0.22 | 1.12 |
| Stochastic Oscillator | 89.35 | 95.96 |
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (49% of sales as of the end of fiscal 2024), chocolate (31%), gum/candy (11%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one-third of its revenue from developing markets, more than one-third from Europe, and the remainder from North America.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.